Reoperation in Bioprosthetic vs Mechanical Aortic Valve Replacement in The Society of Thoracic Surgeons Database
In patients aged ≤63 years, mechanical AVR was associated with lower risk-adjusted reoperation or all-cause mortality compared with bioprosthetic AVR. These contemporary long-term data further inform patient and provider shared clinical decision-making when choosing a prosthetic aortic valve.
Authors
- Tsuyoshi Kaneko (ORCID: https://orcid.org/0000-0001-6500-7471)
- Michael Andrew Borger (ORCID: https://orcid.org/0000-0003-1046-1364)
- Thomas E. MacGillivray (ORCID: https://orcid.org/0000-0003-1248-7891)
- Shu-Ching Chang
- Vinay Badhwar (ORCID: https://orcid.org/0000-0002-7916-3544)
- James Hunter Mehaffey (ORCID: https://orcid.org/0000-0002-0612-7737)
- Shinichi Fukuhara (ORCID: https://orcid.org/0000-0002-7898-5159)
- Joseph F. Sabik (ORCID: https://orcid.org/0000-0002-1186-343X)
- Gregory P. Fontana
- Michael E. Bowdish (ORCID: https://orcid.org/0000-0002-0863-2825)
- Karen Kim (ORCID: https://orcid.org/0000-0002-3987-8051)
Institutions
- West Virginia University (US)
- Cedars-Sinai Medical Center (US)
- MedStar Washington Hospital Center (US)
- Washington University in St. Louis (US)
- University of Michigan (US)
- University Hospitals of Cleveland (US)
- HCA Healthcare (US)
- Society of Thoracic Surgeons (US)
- Leipzig Heart Institute (DE)
- Cedars-Sinai Smidt Heart Institute (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- The Annals of Thoracic Surgery
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.athoracsur.2025.09.047
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00